Bank stocks were helping European equities traded in the US as American depositary receipts nudge marginally higher late Monday morning, rising 0.047% to 1,409.42 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by financial services company ING (ING) and pharmaceutical company Sanofi (SNY), which rose 2.9% and 1.7% respectively. They were followed by financial services company Banco Santander (SAN) and biopharmaceutical company DBV Technologies (DBVT), which were up 1.5% and 1% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX), which tumbled 20.5%, followed by biopharmaceutical company Cellectis (CLLS), which fell 5.8%. They were followed by biotech firm BioNTech (BNTX) and pharmaceutical company Ascendis Pharma (ASND), which were down 2.6% each.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma (VRNA) and Mereo BioPharma Group (MREO), which climbed 10.2% and 4% respectively. They were followed by construction materials supplier CRH (CRH) and financial services company Lloyds Banking Group (LYG), which increased 1.2% and 0.9% respectively.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and pharmaceutical company Silence Therapeutics (SLN), which dropped 13.7% and 2% respectively. They were followed by biopharmaceutical companies Akari Therapeutics (AKTX) and NuCana (NCNA), which lost 2.9% and 2% respectively.
Comments